Here is what matters practically: TRT Nation offers compounded tirzepatide, not semaglutide, because the clinical evidence supports tirzepatide as the superior GLP-1/GIP weight loss therapy for most appropriate candidates
Sun, Z., Wu, J., Bi, Q
The significant variation among the groups underscores the differential impacts of the treatments
A wearable alternative to pills or injections, designed for targeted recovery support
Imagine if you could lose weight and supercharge your health while eating all the ribeye steaks you want but only if you skip the potato and side salad
Flags theoretical pathologic angiogenesis potential: PMC12446177 Evidence summary Preclinical: IBD/colitis models: High remission rates, restored mucosal architecture, improved barrier function Tendon repair: Accelerated healing, improved tensile strength, reduced fibrosis Neurovascular: Sciatic nerve protection, enhanced blood vessel growth in nerve tissue Human data (emerging): Interstitial cystitis pilot (2024, n=12): 10/12 complete resolution, 2/12 at 80% improvement IV safety study (2025, n=2): no adverse effects on cardiac, hepatic, renal, or glucose biomarkers Knee series (Lee): 17 patients identified, 16 analysed